Literature DB >> 28334088

Relapse, re-infection and mixed infections in tuberculosis disease.

Amanda McIvor1, Hendrik Koornhof2, Bavesh Davandra Kana1,3.   

Abstract

Tuberculosis (TB) disease can be characterized by genotypic and phenotypic complexity in Mycobacterium tuberculosis bacilli within a single patient. This microbiological heterogeneity has become an area of intense study due its perceived importance in drug tolerance, drug resistance and as a surrogate measure of transmission rates. This review presents a descriptive analysis of research describing the prevalence of mixed-strain TB infections in geographically distinct locations. Despite significant variation in disease burden and a rampant human immunodeficiency virus (HIV)-TB co-epidemic, there was no difference in the prevalence range of mixed infections reported in African countries when compared to the rest of the world. The occurrence of recurrent TB was associated with a higher prevalence of mixed-strain infections, but this difference was not reported as statistically significant. These interpretations were limited by differences in the design and overall size of the studies assessed. Factors such as sputum quality, culture media, number of repeated culture steps, molecular typing methods and HIV-infection status can affect the detection of mixed-strain infection. It is recommended that future clinical studies should focus on settings with varying TB burdens, with a common sample processing protocol to gain further insight into these phenomena and develop novel transmission blocking strategies. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  heteroresistance; mixed infections; re-infection; recurrent disease; relapse; tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28334088     DOI: 10.1093/femspd/ftx020

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  25 in total

Review 1.  Infect and Inject: How Mycobacterium tuberculosis Exploits Its Major Virulence-Associated Type VII Secretion System, ESX-1.

Authors:  Sangeeta Tiwari; Rosalyn Casey; Celia W Goulding; Suzie Hingley-Wilson; William R Jacobs
Journal:  Microbiol Spectr       Date:  2019-05

2.  Mixed tuberculosis infections in Northwest of Iran.

Authors:  Mohammad Asgharzadeh; Zahra Taghinejad; Behroz Mahdavipoor; Vahid Asgharzadeh; Hossein Samadi Kafil; Jalil Rashedi
Journal:  Infez Med       Date:  2021-12-10

3.  Characterization of the Proportion of Clustered Tuberculosis Cases in Guatemala: Insights from a Molecular Epidemiology Study, 2010-2014.

Authors:  María Eugenia Castellanos; Dalia Lau-Bonilla; Anneliese Moller; Eduardo Arathoon; Blanca Samayoa; Frederick Quinn; Mark Ebell; Kevin Dobbin; Christopher Whalen
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 2.345

4.  Effect of mixed strain infections on clinical and epidemiological features of tuberculosis in Florida.

Authors:  Michael Asare-Baah; Marie Nancy Séraphin; LaTweika A T Salmon; Michael Lauzardo
Journal:  Infect Genet Evol       Date:  2020-12-01       Impact factor: 3.342

5.  Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.

Authors:  Edgar Kigozi; George W Kasule; Kenneth Musisi; Deus Lukoye; Samuel Kyobe; Fred Ashaba Katabazi; Eddie M Wampande; Moses L Joloba; David Patrick Kateete
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

Review 6.  Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse.

Authors:  Janice J Endsley; Matthew B Huante; Kubra F Naqvi; Benjamin B Gelman; Mark A Endsley
Journal:  Retrovirology       Date:  2021-06-16       Impact factor: 4.602

7.  Genetic models of latent tuberculosis in mice reveal differential influence of adaptive immunity.

Authors:  Hongwei Su; Kan Lin; Divya Tiwari; Claire Healy; Carolina Trujillo; Yao Liu; Thomas R Ioerger; Dirk Schnappinger; Sabine Ehrt
Journal:  J Exp Med       Date:  2021-07-16       Impact factor: 14.307

8.  Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention.

Authors:  Andrew Fiore-Gartland; Lindsay N Carpp; Kogieleum Naidoo; Ethan Thompson; Daniel E Zak; Steve Self; Gavin Churchyard; Gerhard Walzl; Adam Penn-Nicholson; Thomas J Scriba; Mark Hatherill
Journal:  Tuberculosis (Edinb)       Date:  2017-11-22       Impact factor: 3.131

9.  Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.

Authors:  Elsje Pienaar; Jennifer J Linderman; Denise E Kirschner
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

10.  Recurrent Tuberculosis Disease in Singapore.

Authors:  Suay Hong Gan; Kyi Win KhinMar; Li Wei Ang; Leo K Y Lim; Li Hwei Sng; Yee Tang Wang; Cynthia B E Chee
Journal:  Open Forum Infect Dis       Date:  2021-06-27       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.